Press Release

<< Back
Printer Friendly Version View printer-friendly version
Depomed to Report Fourth Quarter Fiscal Year 2017 Financial Results on Tuesday, February 27, 2018

NEWARK, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release fourth quarter fiscal year 2017 financial results on Tuesday, February 27, 2018, after the close of markets. The Company will host a conference call beginning at 4:30 p.m. EST (1:30 p.m. PST) to discuss its results.

Participants can access the live webcast from the Investor Relations section of Depomed's website at Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the Company's website for three months.

Audio Conference Call:

U.S. Dial-in Number: 1-844-839-0046
International Dial-in Number:  1-857-270-6032
Conference ID: 2157887

An archived webcast replay will be available on the Company's website for three months.

About Depomed

Depomed is a leading specialty pharmaceutical company committed to putting the Patient First in everything it does. Depomed is focused on enhancing the lives of patients, families, physicians, providers and payors through the commercialization of products in the areas of pain and neurology, and in the development of drugs in areas of unmet medical need. Depomed currently markets three medicines focused on neuropathic pain and migraine through its Neurology and Pain businesses and its emerging Specialty Business is focused on orphan drug indications and areas of unmet medical need. To learn more about Depomed, visit


Christopher Keenan
VP, Investor Relations and Corporate Communications

Daniel Peisert
VP, Business Development

Primary Logo

Depomed, Inc.